$185.31
2.721.49%
Last update: Oct 29, 4:49 PM
Guardant Health Inc
GHNASDAQ
Guardant Health (GH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Guardant Health (GH) last issued guidance on July 30, 2026 for fiscal year 2026. The company guided revenue in the range of $1.34B - $1.36B for the period.
Compared to prior guidance, Guardant Health raised its revenue forecast from a prior range of $1.3B - $1.32B.
Guardant Health has issued 24 guidance updates between November 3, 2022 and July 30, 2026. During this period, the company raised its outlook 18 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.52 | $-0.61 | $-0.61 |
| Actual | $-0.42 | $-0.45 | $-0.50 | $-0.39 |
| Surprise | +8.70% | +13.5% | +18.0% | +36.1% |
| Revenue | ||||
| Estimate | $314.9M | $278.9M | $275.4M | $235.2M |
| Actual | $335.0M | $301.7M | $281.3M | $265.2M |
| Surprise | +6.38% | +8.14% | +2.15% | +12.7% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.39 | $-0.37 | $-0.63 | $-0.59 |
| Revenue | ||||
| Consensus | $350.7M | $369.5M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $-0.42 | $-0.46 | 8.70 % |
| Q1 | May 7, 2026 | $-0.45 | $-0.52 | 13.5 % |
| Q4 | Feb 19, 2026 | $-0.50 | $-0.61 | 18.0 % |
| Q3 | Oct 29, 2025 | $-0.39 | $-0.61 | 36.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $334.98M | $314.90M | 6.38 % |
| Q1 | May 7, 2026 | $301.67M | $278.95M | 8.14 % |
| Q4 | Feb 19, 2026 | $281.27M | $275.35M | 2.15 % |
| Q3 | Oct 29, 2025 | $265.20M | $235.25M | 12.7 % |
